Crossmark

miR-425 suppresses EMT and the development of TNBC (triple-negative breast cancer) by targeting the TGF-β 1/SMAD 3 signaling pathway

Crossref DOI link: https://doi.org/10.1039/C8RA08872A

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Liu, Yingping

Chen, Jinglong https://orcid.org/0000-0002-1374-6317
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (30600524)

National Natural Science Foundation of China (81341067)

Natural Science Foundation of Guangdong Province (2017A030313510)
License Information

Version of Record valid from 2018-12-21
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

IDENTIFIERS

: Jinglong Chen (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 25 October 2018; Accepted 17 December 2018; Version of Record published 21 December 2018